SILK ROAD MEDICAL, INC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.48 USD | +3.07% |
|
+9.90% | +58.27% |
| Apr. 02 | Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuro Protection System Plus | CI |
| Mar. 08 | North American Morning Briefing : Stock Futures -2- | DJ |
Chart calendar Silk Road Medical, Inc
ced2c7b9.xx2A8cPIYCireYkqRI871wutWqI8UpxYt8W3nW5jLnA.jE_rh_erNWScOPkbL8MCkXnYKMh_I6kA7_bExQomeQSdReKljoksEdIoyA~54baec246b631379f36718f2239612e1
Upcoming events on Silk Road Medical, Inc
Past events on Silk Road Medical, Inc
| 2024-02-28 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-28 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-10 04:30 pm | JPMorgan Healthcare Conference |
| 2023-11-08 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-08 04:05 pm | Q3 2023 Earnings Release |
| 2023-09-18 11:45 am | CL King Best Ideas Conference |
| 2023-08-17 02:00 pm | UBS Genomics 2.0 and MedTech Innovations Summit |
| 2023-08-01 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-01 04:05 pm | Q2 2023 Earnings Release |
| 2023-06-21 05:30 pm | Annual General Meeting |
| 2023-05-25 11:00 am | Investor Meeting - Key Opinion Leader |
| 2023-05-10 07:20 pm | Bank of America Healthcare Conference |
| 2023-05-09 04:30 pm | Q1 2023 Earnings Call |
| 2023-05-09 04:05 pm | Q1 2023 Earnings Release |
| 2023-02-28 04:30 pm | Q4 2022 Earnings Call |
| 2023-02-28 04:05 pm | Q4 2022 Earnings Release |
| 2023-01-10 07:30 pm | JP Morgan Healthcare Conference |
| 2022-11-30 03:00 pm | Piper Sandler Healthcare Conference |
| 2022-11-16 01:20 pm | Wolfe Research Healthcare Conference |
| 2022-11-15 10:20 am | Stifel Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 63,4 62,7 0.98% | 75,2 75,4 -0.22% | 101 99,3 2.14% | 139 136 1.65% | 177 172 3.07% | 196 |
|
EBITDA Million USD | Released Forecast Spread | -27,4 -27,6 0.95% | -41,5 -33,7 -22.94% | -46,4 -38,5 -20.6% | -49,9 -44,6 -11.96% | -56,6 -58,5 3.22% | -56,6 |
|
EBIT Million USD | Released Forecast Spread | -28,1 -27,9 -0.75% | -42,9 -36,6 -17% | -47,5 -44,8 -5.89% | -52,0 -52,3 0.51% | -59,3 -61,4 3.43% | -57,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -52,4 -53,0 1.14% | -47,4 -40,7 -16.31% | -49,8 -47,9 -3.98% | -55,0 -56,3 2.22% | -55,7 -58,0 3.89% | -54,4 |
|
Net income Million USD | Released Forecast Spread | -52,4 -52,6 0.35% | -47,4 -40,4 -17.14% | -49,8 -47,5 -4.8% | -55,0 -56,3 2.3% | -55,7 -58,0 3.92% | -54,2 |
|
EPS USD | Released Forecast Spread | -2,28 -1,82 -25.05% | -1,44 -1,24 -15.79% | -1,44 -1,34 -7.08% | -1,54 -1,56 1.43% | -1,44 -1,50 3.69% | -1,37 |
| Announcement Date | 26/02/20 | 01/03/21 | 24/02/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 28,3 25,9 9.1% | 28,0 27,1 3.41% | 33,2 31,0 6.92% | 37,4 33,6 11.12% | 40,1 37,3 7.29% | 40,1 40,7 -1.37% | 45,3 43,2 4.92% | 44,4 44,3 0.22% | 47,3 42,0 12.51% | 44,7 | 48,9 | 49,4 | 52,8 | 50,4 |
|
EBITDA Million USD | Released Forecast Spread | -13,8 -11,6 -18.5% | -15,5 -12,1 -27.95% | -13,7 -14,6 6.26% | -8,68 -12,9 32.53% | -12,0 -10,6 -13.28% | -16,2 -9,97 -62.54% | -13,6 -10,7 -27.91% | -13,0 -14,4 9.52% | -13,7 -15,6 12% | -15,8 | -14,4 | -13,7 | -12,7 | -12,0 |
|
EBIT Million USD | Released Forecast Spread | -14,1 -11,8 -18.89% | -16,0 -12,4 -28.2% | -14,2 -15,9 10.54% | -9,23 -14,1 34.53% | -12,6 -12,7 0.27% | -16,9 -14,5 -16.3% | -14,3 -15,4 7.1% | -13,7 -14,6 6.41% | -14,4 -16,4 12.46% | -16,6 | -15,0 | -14,0 | -12,5 | -14,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,7 -13,7 -7.64% | -16,7 -13,8 -21.3% | -15,4 -17,2 10.48% | -10,3 -15,9 35.24% | -12,6 -13,6 7.25% | -16,5 -14,0 -17.57% | -13,5 -14,8 8.64% | -12,8 -13,9 7.81% | -13,0 -15,3 14.84% | -15,8 | -13,9 | -13,0 | -11,8 | -14,2 |
|
Net income Million USD | Released Forecast Spread | -14,7 -12,7 -15.31% | -16,7 -12,8 -30.28% | -15,4 -16,2 4.97% | -10,3 -15,1 31.75% | -12,6 -13,7 7.99% | -16,5 -14,2 -16.22% | -13,5 -14,9 9.77% | -12,8 -13,8 7.06% | -13,0 -15,2 14.56% | -15,7 | -13,9 | -12,8 | -11,6 | -14,2 |
|
EPS USD | Released Forecast Spread | -0,42 -0,35 -18.61% | -0,48 -0,35 -35.37% | -0,44 -0,46 4.09% | -0,29 -0,43 32.1% | -0,34 -0,38 9.92% | -0,43 -0,38 -13.23% | -0,35 -0,38 8.48% | -0,33 -0,34 3.8% | -0,33 -0,39 15.63% | -0,40 | -0,35 | -0,33 | -0,30 | -0,37 |
| Announcement Date | 24/02/22 | 04/05/22 | 26/07/22 | 08/11/22 | 28/02/23 | 09/05/23 | 01/08/23 | 08/11/23 | 28/02/24 | - | - | - | - | - |
| Today 04:05 pm | SILK ROAD MEDICAL, INC: Q1 2024 Earnings Release |
| Today 04:05 pm | MERIT MEDICAL SYSTEMS, INC.: Q1 2024 Earnings Release |
| 2024-04-30 | REPLIGEN CORPORATION: Q1 2024 Earnings Release |
| 2024-04-30 | BAUSCH + LOMB CORPORATION: Q1 2024 Earnings Release |
| 2024-04-30 | PROCEPT BIOROBOTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:00 am | LIVANOVA PLC: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | CENCORA, INC.: Q2 2024 Earnings Release |
| 2024-05-01 04:01 pm | ATRICURE, INC.: Q1 2024 Earnings Release |
| 2024-05-01 04:10 pm | ENVISTA HOLDINGS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 | TANDEM DIABETES CARE, INC.: Q1 2024 Earnings Release |
Past sector events for Silk Road Medical, Inc
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SILK Stock
- Calendar Silk Road Medical, Inc
